Prof. Shehadeh is a professor at the Faculty of Medicine at the Technion, Director of the Institute of Endocrinology, Diabetes and Metabolism at the Rambam Medical Center, Chairman of the Rambam Patents Committee, President of the Israel Diabetes Association and head of the “Galilee Diabetes SPHERE” program at the Bar Ilan University Faculty of Medicine.

Prof. Shehadeh Naim is a graduate of the Bruce Rappaport Faculty of Medicine at the Technion. He specialized in pediatrics and Endocrinology at Rambam Hospital and completed his medical training at the University of Colorado Health Sciences Center in the USA.

His main research topics are in the field of: pathogenesis and prevention of type 1 diabetes, the effect of orally administered insulin on the digestive system, treatment and prevention of complications in type 2 diabetes. Education for a healthy lifestyle and access to health services for disadvantaged peripheral populations.

Prof. Shehadeh won several research awards from the Technion such as: The Hershel Rich Technion Innovation Award and The Raymond and Miriam Klein Technion Research Award.

Research:

• Gastrointestinal tract as a target organ of oral insulin: studies on the effect of orally administered insulin on the maturation of the GI tract.
• Development of new infant formulas enriched with insulin for better maturation of gastrointestinal system in premature infants. A start-up company was established (Nutrinia) with great success. The new infant formula was developed, and human clinical trial trials are being carried out. Phase 1 and phase 2 trials were completed successfully, and in August 2016, phase 3 studies commenced in Europe and the USA. More than $42 million were raised as investments during the years 2014-2016.
• Metabolic control of diabetic patients.
• Prevention of acute and chronic diabetes complications.